Drug profile · INN
verteporfin
VISUDYNE
verteporfin (VISUDYNE) is a dna inhibitor. Route of administration: injection. Current US regulatory status: approved.
FDA: approved EMA: approved Sensory organs (S01) S01LA01
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — verteporfin
- US status
- approved
- Class
- Sensory organs (S01)
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
verteporfin (VISUDYNE) is a dna inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN verteporfin
Brand VISUDYNE
Mechanism DNA inhibitor
Target DNA
Therapeutic class Sensory organs (S01)
Route INJECTION
Formulation INJECTABLE
ATC code S01LA01
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is verteporfin?
verteporfin (VISUDYNE) is a dna inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for verteporfin?
VISUDYNE is a marketed brand name for verteporfin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of verteporfin?
verteporfin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.